title: In reply.
authors: Division of Drug Development and Regulatory Science Faculty of PharmacyKeio UniversityTokyo, Japan.
authors: Hisashi
authors: H
authors: Urushihara
mesh_terms: D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy*; D017698:Postmenopause; D020849:Raloxifene Hydrochloride / Q000009:adverse effects*; D020521:Stroke
chemical_list: D050071:Bone Density Conservation Agents; D020849:Raloxifene Hydrochloride